Cancer: Leukemia

A progressive, malignant disease of the blood cells and blood forming organs (i.e., bone marrow and spleen).

Likely Underwriting Decision

Preferred is not available.

Standard Plus possible after 10 years of qualifying for Standard rates

The most common type of leukemia seen in underwriting is CLL, which is insurable, if stable, low-stage disease and typically after two years since the diagnosis. CLL diagnosed under age 50 is a decline

For other types of leukemia, depending on the type, coverage may not be available for 5 or more years following diagnosis. Very few cases can be offered coverage

Best Case: (CLL cases) 150 to 200% 5-10 years post treatment

Factors Affecting the Decision

  • Current Age
  • Date of diagnosis
  • Type of leukemia and stage of cancer
  • Treatment
  • Date treatment completed
  • Any recurrence or secondary cancer

Fast Track the App

APS, special blood testing if current results are not provided in the APS

Fast Track:

  • Pathology reports
  • Evidence of regular follow-up
  • Hospital reports
  • Details and date(s) of treatment